Cleveland Clinic 27th Annual Diabetes Therapeutics, Technology and Surgery 2023
$40,00
Samples for Courses Can be found here : Free Samples Here!
Cleveland Clinic 27th Annual Diabetes Therapeutics, Technology and Surgery 2023 is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes.
Cleveland Clinic 27th Annual Diabetes Therapeutics, Technology and Surgery 2023 is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:
- Include: 16 videos + 22 pdfs, size: 1.74 GB
- Target Audience: primary care physicians, endocrinologists, diabetes educators
Overview
The 27th annual Diabetes Day: Therapeutics, Technology and Surgery is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:
- A review of therapeutic options to manage both Type 1 and 2 diabetes and their complications, including a pump update, new insulins, and continuous glucose monitoring updates.
- New data regarding metformin in pregnancy will be discussed.
- Importance of maintaining muscle mass during obesity management.
- Gastroparesis associated with GLP-1 therapy and its effect on pre-op management.
- New roles for GLP1 receptor agonists SGLT-2 inhibitors and mineralocorticoid receptor antagonists in preserving cardiac function and preventing strokes.
This year’s curriculum will also feature discussions about:
- Research from Cleveland Clinic on non-nutritive sweeteners.
- New treatment for nephropathy.
- Pre-prandial vs post prandial exercise.
- Diabetes and dementia.
- Mental health and diabetes.
- Effects of high-fat and high-protein diets on glucose control.
- Dermatologic considerations in diabetes.
The goal of this symposium is to increase practitioners’ competence and clinical performance in treating diabetes and its complications and, ultimately, to improve patient outcomes.
There will be an optional workshop on continuous glucose monitoring designed for healthcare providers to advance the care of their patients with diabetes using continuous glucose monitoring (CGM) and other diabetes technology.
Attendees will be able to:
- Describe the efficacy and side effects of therapeutic interventions for Type 1 and Type 2 diabetes, including new insulins, closed-loop insulin pumps, smart pens, and islet and pancreas transplants.
- Analyze new therapies and critically appraise the roles of SGLT-2 inhibitors, GLP-1 receptor agonists, and mineralocorticoid receptor antagonists to preserve renal and cardiac function.
- Assess goals and management strategies for treating renal insufficiency in patients with diabetes.
- Evaluate the impact of weight loss treatment options, including muscle mass preservation, in patients with Type 2 diabetes.
- Critically appraise the effects of non-nutritive sweeteners.
- Discuss the impact and define treatment strategies for dermatologic manifestations, neurological impairment such as dementia and stroke, and managing pregnancy for patients with diabetes.
Who should attend?
This activity is designed for primary care physicians, endocrinologists, diabetes educators, pharmacists, nurses, nurse practitioners, physician assistants, and other health care professionals who care for patients with diabetes.
Release Date : May 18th 2023
+ Topics:
- Carbs in Pregnancy, How Low Can You Go.mp4
- Carbs in Pregnancy, How Low Can You Go.pdf
- Continuous Glucose Monitoring Keeping Up With Technology and Your Patients.pdf
- Diabetes Management in Older Adults.mp4
- Diabetes Management in Older Adults.pdf
- Diabetes Prevention Teplizumab.mp4
- Diabetes Prevention Teplizumab.pdf
- Glucagon in Emergency Lows, Micro Dosing and Insulin Pumps.mp4
- Glucagon in Emergency Lows, Micro Dosing and Insulin Pumps.pdf
- Insulin Update – Long, Short, Inhaled.mp4
- Insulin Update – Long, Short, Inhaled.pdf
- Insulin Without Hypoglycemia.mp4
- Insulin Without Hypoglycemia.pdf
- Medical vs Surgical Treatment for Diabetes Remission Weight Loss Aminian.pdf
- Medical vs Surgical Treatment for Diabetes Remission Weight Loss Griebeler.pdf
- Medical VS Surgical Treatment.mp4
- Medical VS Surgical Treatment.pdf
- Neuropathy Treatment.mp4
- Neuropathy Treatment.pdf
- New ADA Guidelines for Hypertension and Lipids.mp4
- New ADA Guidelines for Hypertension and Lipids.pdf
- New Therapy for Diabetic Heart Disease.mp4
- New Therapy for Diabetic Heart Disease.pdf
- Non-insulin Treatment in the Hospital.mp4
- Non-insulin Treatment in the Hospital.pdf
- Pancreas Transplant and Islet Transplant Update.mp4
- Pancreas Transplant and Islet Transplant Update.pdf
- Preserving Renal Function in Diabetes.mp4
- Preserving Renal Function in Diabetes.pdf
- Retinopathy Macular Edema.mp4
- Retinopathy Macular Edema.pdf
- Use of Insulin Pumps in Type 2 Diabetes.mp4
- Use of Insulin Pumps in Type 2 Diabetes.pdf
- Workshop 1 – CGM updates.mp4
- Workshop 1 – CGM updates.pdf
- Workshop 1 – Novel Insulin Delivery.pdf
- Workshop 2 – Diabetic Cardiomyopathy.pdf
- Workshop 2 – Non Nutritive Sweeteners.pdf
Related products
CRITICAL CARE / EMERGENCY MEDICINE
Harvard Advanced Trauma Management for the Emergency Physician 2022 (CME VIDEOS)
CRITICAL CARE / EMERGENCY MEDICINE
CRITICAL CARE / EMERGENCY MEDICINE
CRITICAL CARE / EMERGENCY MEDICINE
ASN Critical Care Nephrology – 2022 Update (On-Demand and Livestream)
QBANKS and board review
Critical Care Medicine Board Review Course (ThePassMachine) (Videos+PDFs)
